MiMedx Group, Inc. (NASDAQ: MDXG) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $13.00 price target on the stock.
MIMEDX to Present at TD Cowen 45th Annual Health Care Conference
MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results [Yahoo! Finance]
MiMedx Group, Inc. 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]
MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results